- Report
- December 2024
- 96 Pages
Global
From €3999EUR$4,585USD£3,458GBP
- Report
- September 2024
- 192 Pages
Global
From €4345EUR$4,650USD£3,630GBP
- Report
- January 2024
- 48 Pages
India
- Report
- August 2023
- 172 Pages
Global
From €4345EUR$4,650USD£3,630GBP
- Database
- July 2023
Global
From €336EUR$360USD£281GBP
- Report
- June 2023
Global
From €1402EUR$1,500USD£1,171GBP
- Report
- June 2022
- 55 Pages
Global
From €4625EUR$4,950USD£3,864GBP
- Report
- April 2022
Global
€9344EUR$10,000USD£7,806GBP
- Report
- September 2018
- 15 Pages
Global
- Report
- May 2023
- 80 Pages
Russia
From €1402EUR$1,500USD£1,171GBP
- Report
- January 2024
- 124 Pages
Global
From €3500EUR$4,013USD£3,026GBP
- Report
- January 2025
- 132 Pages
Global
From €888EUR$950USD£742GBP
- Report
- October 2022
- 307 Pages
Global
From €2336EUR$2,500USD£1,951GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more